tiprankstipranks
Trending News
More News >
BriaCell Therapeutics Corp (TSE:BCT)
TSX:BCT
Canadian Market

BriaCell Therapeutics (BCT) Income Statement

Compare
96 Followers

BriaCell Therapeutics Income Statement

Last quarter (Q1 2026), BriaCell Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, BriaCell Therapeutics's net income was C$-8.20M. See BriaCell Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -147.89KC$ -114.04KC$ -20.49KC$ -19.39KC$ -19.44K
Operating Expenses
C$ 37.59MC$ 46.02KC$ 23.27MC$ 19.58KC$ 6.97M
Depreciation and Amortization
C$ 147.89K-C$ 15.27KC$ 15.27KC$ 15.26K
EBITDA
C$ -36.63MC$ -45.91KC$ -27.23MC$ -34.05MC$ -6.95M
Operating Income
C$ -37.73MC$ -46.02KC$ -23.27MC$ -15.29MC$ -6.97M
Other Income/Expenses
C$ 899.71KC$ 39.21KC$ 2.97MC$ -11.69MC$ -8.54K
Pretax Income
C$ -36.83MC$ -6.81KC$ -20.30MC$ -26.84MC$ -13.82M
Net Income
C$ -36.50MC$ -6.62KC$ -20.30MC$ -11.58MC$ -2.90M
Per Share Metrics
Basic EPS
C$ -86.25C$ -4.28C$ -19.79C$ -25.70C$ -46.73
Diluted EPS
C$ -86.25C$ -4.28C$ -19.79C$ -25.70C$ -46.73
Weighted Average Shares Outstanding
423.11K 1.10M 1.04M 1.03M 301.31K
Weighted Average Shares Outstanding (Diluted)
423.11K 1.10M 1.04M 1.03M 301.31K
Currency in CAD

BriaCell Therapeutics Earnings and Revenue History